Back to results
US 2022/0033521 A1Published application
Compositions and methods for treatment of diabetic macular edema
AssigneeTakeda Pharmaceutical Company Limited
InventorsGregory P. Conley, Andrew Nixon, Daniel J. Sexton
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions comprising one or more antibodies that specifically bind active plasma kallikrein (e.g., human plasma kallikrein) and methods of using such compositions for the treatment of retinal diseases, such as diabetic macular edema.
Claims15
A method for treating a retinal disease in a subject, the method comprising:
- administering an effective amount of a composition comprising an antibody to a subject in need thereof, wherein the antibody comprises:
- (i) a heavy chain variable region comprising a complementarity determining region (CDR) 1 set forth as HYIMM (SEQ ID NO:
- 5), a CDR2 set forth as GIYSSGGITVYADSVKG (SEQ ID NO:
- 6), and a CDR3 set forth as QRTGVPRRDSFNI (SEQ ID NO:
- 44), a light chain variable region comprising a CDR1 set forth as RASQSISSWLA (SEQ ID NO:
- 8), a CDR2 set forth as KASTLES (SEQ ID NO:
- 9), and a CDR3 set forth as QQYNTYWT (SEQ ID NO:
- 10);
- (ii) a heavy chain variable region comprising a CDR1 set forth as HYIMM (SEQ ID NO:
- 5), a CDR2 set forth as GIYSSGGITVYADSVKG (SEQ ID NO:
- 6), and a CDR3 set forth as RRTGVPRRDEFDI (SEQ ID NO:
- 46), a light chain variable region comprising a CDR1 set forth as RASQSISSWLA (SEQ ID NO:
- 8), a CDR2 set forth as KASTLES (SEQ ID NO:
- 9), and a CDR3 set forth as QQYNTYWT (SEQ ID NO:
- 10);
- (iii) a heavy chain variable region comprising a CDR1 set forth as HYIMM (SEQ ID NO:
- 5), a CDR2 set forth as GIYSSGGITVYADSVKG (SEQ ID NO:
- 6), and a CDR3 set forth as RRIGVPRRDSFDM (SEQ ID NO:
- 52), a light chain variable region comprising a CDR1 set forth as RASQSISSWLA (SEQ ID NO:
- 8), a CDR2 set forth as KASTLES (SEQ ID NO:
- 9), and a CDR3 set forth as QQYNTYWT (SEQ ID NO:
- 10);
- or
- (iv) a heavy chain variable region comprising a CDR1 set forth as HYIMM (SEQ ID NO:
- 5), a CDR2 set forth as GIYSSGGITVYADSVKG (SEQ ID NO:
- 6), and a CDR3 set forth as RRIGVPRRDDFDI (SEQ ID NO:
- 53), a light chain variable region comprising a CDR1 set forth as RASQSISSWLA (SEQ ID NO:
- 8), a CDR2 set forth as KASTLES (SEQ ID NO:
- 9), and a CDR3 set forth as QQYNTYWT (SEQ ID NO:
- 10).
27 more elements
-8. (canceled)
-23. (canceled)
-27. (canceled)
-33. (canceled)
Dependencies are inferred from the claim text.